Galvin, Gaustad & Stein, LLC United Therapeutics Corp Transaction History
Galvin, Gaustad & Stein, LLC
- $1.06 Billion
- Q4 2024
A detailed history of Galvin, Gaustad & Stein, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 26,512 shares of UTHR stock, worth $8.3 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
26,512
Previous 25,007
6.02%
Holding current value
$8.3 Million
Previous $8.96 Million
4.39%
% of portfolio
0.89%
Previous 0.84%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.73 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.39 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$864 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$771 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...